Bauzon M - Search Results

1

Development and validation of a robust and versatile one-plasmid regulated gene expression system.

Szymanski P, Kretschmer PJ, Bauzon M, Jin F, Qian HS, Rubanyi GM, Harkins RN, Hermiston TW. Szymanski P, et al. Among authors: bauzon m. Mol Ther. 2007 Jul;15(7):1340-7. doi: 10.1038/sj.mt.6300171. Epub 2007 May 1. Mol Ther. 2007. PMID: 17505483 Free article.

2

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region.

Hawkins LK, Johnson L, Bauzon M, Nye JA, Castro D, Kitzes GA, Young MD, Holt JK, Trown P, Hermiston TW. Hawkins LK, et al. Among authors: bauzon m. Gene Ther. 2001 Aug;8(15):1123-31. doi: 10.1038/sj.gt.3301507. Gene Ther. 2001. PMID: 11509942

3

Multigene expression from a replicating adenovirus using native viral promoters.

Bauzon M, Castro D, Karr M, Hawkins LK, Hermiston TW. Bauzon M, et al. Mol Ther. 2003 Apr;7(4):526-34. doi: 10.1016/s1525-0016(03)00023-6. Mol Ther. 2003. PMID: 12727116 Free article.

4

The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p).

Shen BH, Bauzon M, Hermiston TW. Shen BH, et al. Among authors: bauzon m. Gene Ther. 2006 Jun;13(12):986-90. doi: 10.1038/sj.gt.3302736. Epub 2006 Mar 9. Gene Ther. 2006. PMID: 16525485

5

Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based delivery.

Petry H, Cashion L, Szymanski P, Ast O, Orme A, Gross C, Bauzon M, Brooks A, Schaefer C, Gibson H, Qian H, Rubanyi GM, Harkins RN. Petry H, et al. Among authors: bauzon m. J Interferon Cytokine Res. 2006 Oct;26(10):699-705. doi: 10.1089/jir.2006.26.699. J Interferon Cytokine Res. 2006. PMID: 17032164

6

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.

Kuhn I, Harden P, Bauzon M, Chartier C, Nye J, Thorne S, Reid T, Ni S, Lieber A, Fisher K, Seymour L, Rubanyi GM, Harkins RN, Hermiston TW. Kuhn I, et al. Among authors: bauzon m. PLoS One. 2008 Jun 18;3(6):e2409. doi: 10.1371/journal.pone.0002409. PLoS One. 2008. PMID: 18560559 Free PMC article.

7

Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.

Bauzon M, Hermiston TW. Bauzon M, et al. Curr Opin Mol Ther. 2008 Aug;10(4):350-5. Curr Opin Mol Ther. 2008. PMID: 18683099 Review.

8

In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer.

Bauzon M, Jin F, Kretschmer P, Hermiston T. Bauzon M, et al. Gene Ther. 2009 Sep;16(9):1169-74. doi: 10.1038/gt.2009.69. Epub 2009 May 21. Gene Ther. 2009. PMID: 19458647

9

Oncolytic viruses: the power of directed evolution.

Bauzon M, Hermiston TW. Bauzon M, et al. Adv Virol. 2012;2012:586389. doi: 10.1155/2012/586389. Epub 2011 Jul 24. Adv Virol. 2012. PMID: 22312363 Free PMC article.

10

Armed therapeutic viruses - a disruptive therapy on the horizon of cancer immunotherapy.

Bauzon M, Hermiston T. Bauzon M, et al. Front Immunol. 2014 Feb 24;5:74. doi: 10.3389/fimmu.2014.00074. eCollection 2014. Front Immunol. 2014. PMID: 24605114 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters